Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableLooking for participantsNCT06311708
What this trial is testing

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics 200
Not applicableEnded earlyNCT01271816
What this trial is testing

Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Patients

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100
Not applicableUnknownNCT02989480
What this trial is testing

PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC

Who this might be right for
SarcoidosisArrhythmogenic Right Ventricular Cardiomyopathy
University of Aberdeen 20
Not applicableEnrolling By InvitationNCT07050160
What this trial is testing

Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant

Who this might be right for
Arrhythmogenic CardiomyopathyPKP2-ACMPKP2-ARVC
Lexeo Therapeutics 10
Not applicableStudy completedNCT02302274
What this trial is testing

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

Who this might be right for
Brugada SyndromeArrhythmogenic Right Ventricular Cardiomyopathy
NYU Langone Health 209
Not applicableStudy completedNCT01804699
What this trial is testing

National ARVC Data Registry and Bio Bank

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
University of British Columbia 1,500
Early research (Phase 1)Looking for participantsNCT06228924
What this trial is testing

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics 15
Not applicableLooking for participantsNCT06976606
What this trial is testing

Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Who this might be right for
Arrhythmogenic CardiomyopathyPKP2-ACMPKP2-ARVC
Lexeo Therapeutics 40
Not applicableStudy completedNCT00083395
What this trial is testing

Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy

Who this might be right for
Arrhythmic Right Ventricular Cardiomyopathy
National Institutes of Health Clinical Center (CC) 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06109181
What this trial is testing

Gene Therapy for ACM Due to a PKP2 Pathogenic Variant

Who this might be right for
Arrhythmogenic CardiomyopathyPKP2-ACMPKP2-ARVC
Lexeo Therapeutics 10
Not applicableUnknownNCT05024708
What this trial is testing

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
Rennes University Hospital 60
Not applicableEnrolling By InvitationNCT04189822
What this trial is testing

Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank

Who this might be right for
Sudden Cardiac ArrestSudden Arrhythmic Death SyndromeArrhythmogenic Right Ventricular Cardiomyopathy (ARVC)+3 more
University of British Columbia 10,000
Testing effectiveness (Phase 2)Temporarily pausedNCT06275893
What this trial is testing

IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

Who this might be right for
Arrhythmogenic Right Ventricular DysplasiaArrhythmogenic Left Ventricular CardiomyopathyArrhythmogenic Right Ventricular Cardiomyopathy 1+4 more
Implicit Bioscience 5
Testing effectiveness (Phase 2)Study completedNCT03685149
What this trial is testing

Pilot Randomized Trial With Flecainide in ARVC Patients

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
University of Rochester 22
Early research (Phase 1)Looking for participantsNCT05885412
What this trial is testing

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Who this might be right for
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc. 9
Not applicableStudy completedNCT02291393
What this trial is testing

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
The Leeds Teaching Hospitals NHS Trust 20
Not applicableLooking for participantsNCT06040242
What this trial is testing

Arrhythmogenic Activity During Exercise in ARVC Patients

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
Swiss Federal Institute of Technology 64